Tech Company Inital Public Offerings
Constellation Pharmaceuticals IPO
Constellation Pharmaceuticals, operating out of Cambridge, debuted as a public company on 7/18/2018.
Transaction Overview
Company Name
Announced On
7/18/2018
Transaction Type
IPO
Amount
$60,000,000
Proceeds Purpose
The company will use the proceeds to fund the advancement of its pipeline of drug treatment candidates.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 First St. 200
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Constellation Pharmaceuticals (Nasdaq: CNST) is the leading biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of epigenetics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jigar Raythatha
Chief Financial Officer
Emma Reeve
Chief Medical Officer
Adrian Senderowicz
Vice President
Patrick Trojer
VP - Bus. Development
Brad Prosek
VP - Human Resources
Brenda Sousa
Browse more venture capital transactions:
Prev: 7/18/2018: Polares Medical venture capital transaction
Next: 7/18/2018: Airy3d venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs